skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Datamonitor Healthcare attended the Jefferies 2013 Global Healthcare Conference held in London over 20–21 November 2013. This analysis review covers a panel discussion about the changing pharma business model and key highlights from presentations by AbbVie, Actelion, Lundbeck, Novartis, Novo Nordisk, and Sanofi.

 

At the conference, five chief executive officers (CEOs) discussed the key topics that companies must now consider when planning their future strategies, including diversification versus core business focus, adapting to regulatory pressures, and how to approach emerging markets.

Download our free white paper for a comprehensive overview

  • Innovative payment agreements as a solution to funding for costly new medicines
  • The impact of the AMNOG assessment on drug prices in Germany and the ongoing challenges in the AMNOG process
  • Growing use of patient-reported outcomes in reimbursement decisions
  • Current experience with early HTA advice

Eyeforpharma-Conference-Review

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: